Urticarial testing including laboratory and in-office testing was all negative. There was no significant contributing family history of disease. She also denied any other associated symptoms such as swelling, difficulty in breathing, dizziness, or any systemic symptoms. The patient’s skin lesions were described as erythematous, pinpoint papules which covered the entire body but spared the face. An ice cube test was performed and was negative. All laboratory findings of a total blood count number, basic metabolic panel, tryptase, C-reactive protein, aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin, alkaline phosphatase, chronic urticarial index, and thyroid panel were (Rac)-Antineoplaston A10 within normal limits. The patient was initiated on oral hydroxyzine therapy for cold-induced (Rac)-Antineoplaston A10 cholinergic urticaria and saw success with symptomatic improvement. The exact mechanisms of both cold and Rabbit Polyclonal to OR6C3 cholinergic urticaria are unclear. The first report of a patient with cold urticaria was explained in 1866 [1]. Chilly urticaria is believed to be associated skin antigens manifested during cold publicity which are detected by IgE antibodies leading to mast cell (Rac)-Antineoplaston A10 activation and histamine release [2]. Cholinergic urticaria was first explained in 1924 [3]. A suggested mechanism of cholinergic urticaria includes an allergic response to sweat antigens [2]. However , it is also seen in a patient with anhidrosis [4]. In cold-induced cholinergic urticaria, Ormerod et al. [5] proposes a common circulating element, like IgE, leading to urticaria. Kaplan and Garofalo [6] first explained cold-induced cholinergic urticaria in 1981 in four patients who clinically demonstrated cholinergic appearing urticaria caused by chilly exposure. These patients showed morphological cholinergic urticaria in the setting of negative ice cube testing. Only one of those patients, an adult, had a similar history to our patient in this urticaria presented with exercising only in a chilly environment. Geller [7] explained a 9-year-old patient with cholinergic appearing urticaria with cold publicity but was not induced with physical activity. In a study of 220 patients with a history of cold urticaria, fifteen concomitantly had cholinergic urticaria because determined by positive ice cube and methacholine testing [8]. Two had unfavorable ice cube tests but positive methacholine tests and were thus called cold-induced cholinergic urticaria. Ormerod et al. [5] described thirteen patients with cold-induced cholinergic urticaria defined by testing. Each had cholinergic urticaria from sweat provoking stimuli and then morphologically cholinergic urticaria in the setting of chilly contact or cold publicity. Other patients have been explained who develop cholinergic and cold urticaria but are not exclusively seen together [2]. Our patient is unique in that the urticaria is only seen with exercise in the cold. Outside of preventing precipitating factors, treatment of cold-induced cholinergic urticaria should initiate with antihistamine therapy. In our case and other descriptions of the disease, antihistamines were used and have generally been successful. In the setting of antihistamine failure, omalizumab has been suggested. The clinical discernment of urticarial disease requires a rigid history collection strategy in order to remove triggers accurately. To our knowledge, this is the first pediatric patient with genuine cold-induced cholinergic urticaria. == Competing Interests == The authors of (Rac)-Antineoplaston A10 this manuscript have no (Rac)-Antineoplaston A10 financial competing interests to disclose. == Authors’ Contributions == Tina Abraham, DO, David P. McGarry, DO, Steve Frith, DO, and Robert Hostoffer, DO, were involved in the.